IRCT20200105046010N63招募中未知
In- Vivo Bioequivalence study of Mesalasine 500 mg EC tablet Faran shimi Pharma with brand drugs (Asacol® 400 mg ER. Tablets. ?Tillotts Pharma AG, Switzerland) in Iranian healthy volunteers.
Pharan shimi Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •General health
- •Body mass index between18-28
- •Informed consent
- •Being at the age of 18-60 years old
排除标准
- •A history of cardiovascular disease
- •A history of liver & kidney disease
- •Alcohol & Drug addiction
- •Hypersensitivity to the drug
研究者
相似试验
招募中
不适用
In-vivo Bioequivalence study of Mezasa granules with brand drugs (PENTASA Ferring Pharmaceuticals Co, Gremany)Bio equivalence test.IRCT20200105046010N40Koushan Pharmed Pharmaceutical Company24
招募中
Unknown
Comparative in vivo evaluation of 2 Mesalazine 500 mg ER Capsule and Mesalazine 500 mg ER Tablet formulations.Ulcerative colitisIRCT20180620040164N46Karen Pharma and Food Supplement Co.24
已完成
Unknown
Comparative in vivo evaluation of 2 Mesalazine 500 mg ER Capsule and PENTASA® 500 mg ER Tablet formulations.Ulcerative colitisIRCT20180620040164N49Actover Pharmaceutical Co.24
招募中
不适用
In-vivo Bioequivalence Test of MODACOLIT SR Granules with brand drug (Ferring Pharmaceuticals Co, Gremany)Bio equivalence test.IRCT20200105046010N50Teb Mofid Nikan Pharmaceutical Co.24
招募中
Unknown
Bioequivalence study of Mesalazine 1200 mg sustained release tabletThis study is performed on healthy volunteers and drug concentration in plasma is determined..IRCT20200105046010N94Tasnim company24